Skip to Content

Sulfacetamide sodium ophthalmic Pregnancy and Breastfeeding Warnings

Sulfacetamide sodium ophthalmic is also known as: AK-Sulf, Bleph-10, Cetamide, Isopto Cetamide, Ocu-Sul 10, Ocu-Sul 15, Ocu-Sul 30, Ocusulf-10, Sodium Sulamyd, Sulf-10, Sulfac 10%, Sulfacet Sodium

Sulfacetamide sodium ophthalmic Pregnancy Warnings

Animal studies have not been reported. There are no controlled data in human pregnancy; unknown if sulfonamides can cause fetal harm when applied topically to pregnant women. Sulfonamides have been reported to cross the placenta to the fetus during all stages of gestation. Oral sulfonamides have not been reported to pose a significant teratogenic risk; however, kernicterus may occur in the newborn if a pregnant woman is treated with such agents at term. With the maternal blood levels expected when the drug is administered by the ophthalmic route, risk to the fetus would be expected to be minimal. AU TGA pregnancy category C: Drugs which, owing to their pharmacological effects, have caused or may be suspected of causing, harmful effects on the human fetus or neonate without causing malformations. These effects may be reversible. Accompanying texts should be consulted for further details. US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

AU: Sulfonamides should be avoided during the last month of pregnancy, if possible. US: This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus. AU TGA pregnancy category: C US FDA pregnancy category: C

See references

Sulfacetamide sodium ophthalmic Breastfeeding Warnings

Sulfonamides administered systemically to lactating women may cause kernicterus in their breastfeeding infants.

A decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother. Excreted into human milk: Data not available Excreted into animal milk: Data not available Comments: -Systemic sulfonamides are excreted into breast milk. -Some systemic sulfonamides are considered compatible with breastfeeding of healthy full-term infants by the American Academy of Pediatrics.

See references

References for pregnancy information

  1. "Product Information. Sulamyd Ophthalmic Solution (sodium sulfacetamide ophthalmic)." Schering Corporation, Kenilworth, NJ.

References for breastfeeding information

  1. "Product Information. Sulamyd Ophthalmic Solution (sodium sulfacetamide ophthalmic)." Schering Corporation, Kenilworth, NJ.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.